Accessibility Menu
Lifeward logo

Lifeward(NASDAQ) LFWD

Current Price$7.37
Market Cap$19.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-100%
5 Year-94%
1 Year-29%
1 Month+2%
Lifeward last closing stock price
MetricPriceDate
Last closeUSD 7.052026-07-24
Lifeward stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.87%USD 7.912026-07-17
1 month+1.59%USD 6.942026-06-24
3 month-4.47%USD 7.382026-04-24
Year to date+1.89%USD 6.922025-12-31
1 year-28.93%USD 9.922025-07-24
3 year-88.66%USD 62.162023-07-25
5 year-93.96%USD 116.762021-07-23
Since inception-99.99%USD 53,760.042014-09-12

Lifeward Financials at a Glance

Market Cap

$19.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$20.92M

Net Income (TTM)

-$25.87M

EPS (TTM)

-$19.68

P/E Ratio

-0.36

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$7.37

Volume

0

Open

$7.37

Previous Close

$7.37

Daily Range

$7.37 - $7.37

52-Week Range

$4.14 - $10.56

Estimated Earnings Date

Aug 13, 2026

LFWD News

Foolcom-Featured.png

Lifeward Sales Fall 15%, Miss Forecast

Motley Fool Markets TeamAug 14, 2025
RWLK

Can ReWalk Keep Moving After Last Week's 25% Pop?

Rick MunarrizDec 28, 2015

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lifeward

Lifeward creates wearable robotic devices that help people with mobility challenges walk again. Its products support those with spinal cord injuries or recovering from strokes. These devices allow users to stand, walk, and move more independently in daily life.

Gadgets That Get You Moving: Products and Services

  • ReWalk Exoskeletons: Wearable robotic suits for people with spinal cord injuries; main revenue driver.
  • AlterG Anti-Gravity Systems: Treadmills using air pressure to reduce body weight for rehabilitation; significant revenue contributor.
  • ReStore Exo-Suit: Soft wearable device for stroke rehabilitation in clinics; EU sales ended May 2024.
  • MyoCycle FES Cycles: Exercise bikes using electrical stimulation for rehabilitation; distribution rights no longer exclusive.
  • Services: Includes consumables, extended warranties, and maintenance for device users and clinics.

Plot Twists and Power Moves: Growth and Expansion

  • Acquired AlterG in August 2023, expanding into anti-gravity rehabilitation devices.
  • Launched ReWalk 7 in the U.S. (March 2025) and Europe (September 2025).
  • Entered an exclusive distribution deal with CorLife (U.S.) and a distribution deal with Verita Neuro (Mexico, Thailand, UAE) in 2025.
  • Transitioned ReWalk manufacturing in-house in Q2 2025; moved AlterG production to Cirtronics in January 2025.
  • Announced planned acquisition of Oratech (pending) and IP purchase from Skelable Ltd. in early 2026.

What Makes Lifeward Stand Out

Lifeward operates in the U.S. Europe, and select global markets through direct sales and distributors. Its devices hold unique regulatory approvals, such as FDA clearance for stair use, and use patented technology for natural movement. The company partners with major insurers and clinics, supporting adoption in rehabilitation and home settings.

Five Things You Need to Know

  • Revenue was $5 million in Q4 2025, down 32.7% from Q4 2024.
  • Gross profit was $1 million in Q4 2025, down 41.0% year-over-year.
  • Net loss improved to $5 million in Q4 2025, from $15 million in Q4 2024.
  • Cash and cash equivalents were $2.2 million as of December 31, 2025.

Bottom Line

Lifeward has diversified its product range and expanded globally through acquisitions and partnerships. The company faces ongoing financial challenges but continues to adapt its business model and technology.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

81

CEO

William Mark Grant

Website

www.golifeward.com

Headquarters

Yokneam Illit, MA 2069203, IL

LFWD Financials

Key Financial Metrics (TTM)

Gross Margin

36.55%

Operating Margin

-120.25%

Net Income Margin

-123.66%

Return on Equity

-243.14%

Return on Capital

-132.01%

Return on Assets

-77.42%

Earnings Yield

-2.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$19.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.81M

Volume

0

Avg. Volume

11.78K

Financials (TTM)

Gross Profit

$7.65M

Operating Income

-$25.16M

EBITDA

-$16.94M

Operating Cash Flow

-$15.01M

Capital Expenditure

-$10.00K

Free Cash Flow

-$15.02M

Cash & ST Invst.

$11.42M

Total Debt

$8.81M

Lifeward Performance Analysis

Lifeward annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 5,511,000-7.6%
20232023-12-31USD 13,854,000151.4%
20242024-12-31USD 25,663,00085.2%
20252025-12-31USD 22,034,000-14.1%
Lifeward sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3013.7%
Q32025-09-308.2%
Q42025-12-31-18.0%
Q12026-03-31-22.8%
Lifeward annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -26.3518.1%
20232023-12-31USD -31.1318.1%
20242024-12-31USD -39.9628.4%
20252025-12-31USD -17.16-57.1%
Lifeward sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-26.1%
Q32025-09-3065.5%
Q42025-12-31-50.0%
Q12026-03-31-86.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.92M

-22.1%

Gross Profit

$1.34M

-36.8%

Gross Margin

34.21%

N/A

Market Cap

$19.84MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$244.96K

N/A

Employees

81

N/A

Net Income

-$10.79M

-123.3%

EBITDA

-$4.85M

-3.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$11.42M

+99.4%

Total Debt

$8.81M

+1323.9%

Accounts Receivable

$5.66M

+9.7%

Inventory

$6.25M

-8.1%

Long Term Debt

$8.39M

+17377.1%

Short Term Debt

$425.00K

-25.6%

Return on Assets

-77.42%

N/A

Return on Invested Capital

-1.10%

N/A

Free Cash Flow

-$3.68M

+33.2%

Operating Cash Flow

-$3.68M

+33.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IINNInspira Technologies Oxy B.H.N. Ltd.
$0.91-23.22%
INABIN8bio, Inc.
$1.20+0.84%
RNAZTransCode Therapeutics, Inc.
$5.93-18.21%
PTHLPheton Holdings Ltd Class A Ordinary Shares
$0.28-5.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
SOFISoFi Technologies
$16.46-0.01%
FFord Motor Company
$14.37+0.02%

Questions About LFWD

What is the current price of Lifeward?

Lifeward is trading at $7.37 per share.

What is the 52-week range for Lifeward?

Over the past 52 weeks, Lifeward has traded between $4.14 and $10.56.

How much debt does Lifeward have?

As of the most recent reporting period, Lifeward reported total debt of $8.81M.

How much cash does Lifeward have on hand?

Lifeward reported $11.43M in cash and cash equivalents in its most recent financial results.

What is Lifeward’s dividend yield?

Lifeward does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services